Table 3 Standardized incidence ratio of TC after DST in different situations.
| Â | Different time | Different treatments | ||||||
|---|---|---|---|---|---|---|---|---|
2-11months | 12-59months | 60-119months | 120 + months | Total | Radiotherapy | Chemotherapy | Surgery | |
Observed SIR(95%CI) | Observed SIR(95%CI) | Observed SIR(95%CI) | Observed SIR(95%CI) | Observed SIR(95%CI) | Observed SIR(95%CI) | Observed SIR(95%CI) | Observed SIR(95%CI) | |
DST | 438 3.77*((3.43–4.14) | 639 1.95*(1.80–2.10) | 271 1.31*(1.16–1.48) | 112 1.14(0.94–1.37) | 1460 1.95*(1.85–2.05) | 261 2.35*(2.08–2.66) | 641 2.33*(2.15–2.52) | 1230 1.97*(1.86–2.09) |
EC | 23 5.21*(3.30–7.81) | 14 1.82(0.99–3.05) | 6 1.68(0.62–3.66) | 0 0.00(0.00-2.59) | 43 2.51*(1.82–3.39) | 35 3.43*(2.39–4.78) | 37 3.34*(2.35–4.60) | 29 3.06*(2.05–4.40) |
GC | 53 6.02*(4.51–7.87) | 43 2.18*(1.58–2.93) | 16 1.48(0.85–2.41) | 6 1.33(0.49–2.90) | 118 2.69*(2.23–3.22) | 36 2.76*(1.93–3.82) | 70 3.09*(2.41–3.91) | 99 2.78*(2.26–3.38) |
SIC | 19 5.60*(3.37–8.75 ) | 38 3.36*(2.38–4.61) | 10 1.39(0.66–2.55) | 5 1.63(053-3.81) | 72 2.88*(2.25–3.63) | 2 2.19(0.26–7.90) | 21 2.92*(1.81–4.46) | 73 2.92*(2.29–3.67) |
CC | 162 3.35*(2.86–3.91) | 289 1.801*(1.60–2.02) | 128 1.18(0.98–1.40) | 55 1.04(0.79–1.36) | 634 1.71*(1.58–1.85) | 11 1.74(0.87–3.12) | 257 2.15*(1.90–2.43) | 626 1.74*(1.61–1.88) |
RC | 63 3.76*(2.89–4.81) | 112 1.96*(1.62–2.36) | 54 1.37*(1.03–1.79) | 20 1.00(0.61–1.55) | 249 1.87*(1.65–2.12) | 163 2.27*(1.93–2.64) | 201 2.36*(2.05–2.71) | 310 1.92*(1.71–2.15) |
HCC | 29 3.90*(2.61–5.61) | 19 1.34(0.80–2.09) | 10 1.81(0.87–3.33) | 3 1.61(0.33–4.70) | 61 2.10*(1.61–2.70) | 5 2.76(0.90–6.44) | 24 1.80*(1.15–2.67) | 33 2.12*(1.46–2.98) |
PC | 23 2.09*(1.33–3.14) | 37 2.87*(2.02–3.95) | 15 3.56*(1.99–5.88) | 5 3.48*(1.13–8.12) | 80 2.71*(2.15–3.37) | 9 1.34(0.61–2.54) | 31 1.87*(1.27–2.66) | 60 3.64*(2.78–4.69) |
